These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 26723758)

  • 1. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study.
    Byrne EH; Anahtar MN; Cohen KE; Moodley A; Padavattan N; Ismail N; Bowman BA; Olson GS; Mabhula A; Leslie A; Ndung'u T; Walker BD; Ghebremichael MS; Dong KL; Kwon DS
    Lancet Infect Dis; 2016 Apr; 16(4):441-8. PubMed ID: 26723758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
    Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
    Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.
    Balkus JE; Brown ER; Hillier SL; Coletti A; Ramjee G; Mgodi N; Makanani B; Reid C; Martinson F; Soto-Torres L; Abdool Karim SS; Chirenje ZM
    Contraception; 2016 Jan; 93(1):25-31. PubMed ID: 26519646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.
    Grabowski MK; Gray RH; Makumbi F; Kagaayi J; Redd AD; Kigozi G; Reynolds SJ; Nalugoda F; Lutalo T; Wawer MJ; Serwadda D; Quinn TC; Tobian AAR
    Lancet Glob Health; 2015 Aug; 3(8):e478-e486. PubMed ID: 26094162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planning for Outcomes (P
    Lebetkin E; Gao X; Taylor D; Maldonado LY; Saad A; Steiner MJ; Dorflinger LJ; Nanda K; Mastro TD
    Glob Health Sci Pract; 2019 Jun; 7(2):317-328. PubMed ID: 31189699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial.
    Hofmeyr GJ; Singata-Madliki M; Lawrie TA; Bergel E; Temmerman M
    Reprod Health; 2016 Apr; 13():42. PubMed ID: 27091008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort.
    Kleinschmidt I; Rees H; Delany S; Smith D; Dinat N; Nkala B; McIntyre JA
    Contraception; 2007 Jun; 75(6):461-7. PubMed ID: 17519153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-Evaluating the Possible Increased Risk of HIV Acquisition With Progestin-Only Injectables Versus Maternal Mortality and Life Expectancy in Africa: A Decision Analysis.
    Rodriguez MI; Gaffield ME; Han L; Caughey AB
    Glob Health Sci Pract; 2017 Dec; 5(4):581-591. PubMed ID: 29284696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.
    Heffron R; Donnell D; Rees H; Celum C; Mugo N; Were E; de Bruyn G; Nakku-Joloba E; Ngure K; Kiarie J; Coombs RW; Baeten JM;
    Lancet Infect Dis; 2012 Jan; 12(1):19-26. PubMed ID: 21975269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
    Bosinger SE; Tharp GK; Patel NB; Zhao C; Payne TL; Dietz Ostergaard S; Butler K; Ellis S; Johnson RL; Kersh EN; McNicholl JM; Vishwanathan SA
    Am J Reprod Immunol; 2018 Oct; 80(4):e13029. PubMed ID: 30076667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraception use and impact on pregnancy prevention in women participating in an HIV prevention trial in South Africa.
    Moodley J; Naidoo S; Wand H; Ramjee G;
    J Fam Plann Reprod Health Care; 2016 Jan; 42(1):5-11. PubMed ID: 26259895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial.
    Crook AM; Ford D; Gafos M; Hayes R; Kamali A; Kapiga S; Nunn A; Chisembele M; Ramjee G; Rees H; McCormack S
    Hum Reprod; 2014 Aug; 29(8):1810-7. PubMed ID: 24838704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
    Morrison CS; Skoler-Karpoff S; Kwok C; Chen PL; van de Wijgert J; Gehret-Plagianos M; Patel S; Ahmed K; Ramjee G; Friedland B; Lahteenmaki P
    AIDS; 2012 Feb; 26(4):497-504. PubMed ID: 22156973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes to the World Health Organization guideline on hormonal contraceptive eligibility for women at high risk of HIV: South African perspective and response.
    Nene Z; Hofmeyr GJ; Patel M; Panday M; Rees H; Makua M; Pillay Y
    S Afr Med J; 2018 Jul; 108(8):629-631. PubMed ID: 30182875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994-2012.
    Wall KM; Kilembe W; Vwalika B; Htee Khu N; Brill I; Chomba E; Johnson BA; Haddad L; Tichacek A; Allen S
    Contraception; 2015 Jun; 91(6):480-7. PubMed ID: 25708502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa.
    McCoy SI; Zheng W; Montgomery ET; Blanchard K; van der Straten A; de Bruyn G; Padian NS
    AIDS; 2013 Mar; 27(6):1001-1009. PubMed ID: 23698064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission.
    Buckner LR; Drobnis EZ; Augustine MS; Rogers LK; Akers J; Mott PD; Hope TJ; Quayle AJ; Schust DJ
    PLoS One; 2019; 14(5):e0214152. PubMed ID: 31095572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda.
    Kiddugavu M; Makumbi F; Wawer MJ; Serwadda D; Sewankambo NK; Wabwire-Mangen F; Lutalo T; Meehan M; Xianbin ; Gray RH;
    AIDS; 2003 Jan; 17(2):233-40. PubMed ID: 12545084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.
    Hapgood JP; Kaushic C; Hel Z
    Endocr Rev; 2018 Feb; 39(1):36-78. PubMed ID: 29309550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.